封面
市場調查報告書
商品編碼
1980694

全球心臟定位市場規模、佔有率、趨勢和成長分析報告(2026-2034)

Global Cardiac Mapping Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計心臟定位市場將從 2025 年的 39.8 億美元成長到 2034 年的 68.6 億美元,2026 年至 2034 年的複合年成長率為 6.22%。

由於心血管疾病發病率的上升以及對先進診斷技術需求的成長,全球心臟定位市場正在快速成長。心臟定位系統能夠幫助醫師分析心臟的電活動,進而診斷及治療心律不整及其他心臟疾病。這些系統廣泛應用於電生理檢查和微創心臟治療。

心臟影像技術的進步、導管介入手術的日益普及以及醫療保健投資的增加,是推動市場成長的主要因素。醫院和專科心臟中心正擴大採用先進的標測系統,以提高診斷準確性和治療效果。此外,人口老化也促使人們對心臟護理技術的需求不斷成長。

展望未來,隨著醫學影像、數據分析和數位醫療解決方案的不斷創新,心臟定位市場預計將持續擴張。更精準、微創的心臟診斷工具的研發將進一步提升治療效率。隨著醫療機構日益重視心臟疾病的管理,對心臟定位技術的需求預計將持續成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球心臟定位市場:依產品類型分類

  • 市場分析、洞察與預測
  • 非接觸式心臟定位系統
  • 接觸式心臟定位系統

第5章:全球心臟定位市場:依適應症分類

  • 市場分析、洞察與預測
  • 心房顫動
  • 心房撲動
  • 房室結折返性心搏過速(AVNRT)

第6章:全球心臟定位市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 專科診所
  • 心臟中心

第7章 全球心臟定位市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Acutus Medical Inc
    • Koninklijke Philips NV
    • Johnson & Johnson Services Inc
    • Boston Scientific Corporation
    • Lepu Medical Technology(Beijing)Co. Ltd
    • Medtronic
    • MicroPort Scientific Corporation
    • APN Health LLC
    • AngioDynamics
簡介目錄
Product Code: VMR112114930

The Cardiac Mapping Market size is expected to reach USD 6.86 Billion in 2034 from USD 3.98 Billion (2025) growing at a CAGR of 6.22% during 2026-2034.

The Global Cardiac Mapping Market is growing rapidly due to the increasing prevalence of cardiovascular diseases and the rising demand for advanced diagnostic technologies. Cardiac mapping systems help physicians analyze the electrical activity of the heart to diagnose and treat arrhythmias and other heart conditions. These systems are widely used during electrophysiology procedures and minimally invasive cardiac treatments.

Market growth is driven by technological advancements in cardiac imaging, increasing adoption of catheter-based procedures, and rising healthcare investments. Hospitals and specialized cardiac centers are increasingly using advanced mapping systems to improve diagnostic accuracy and treatment outcomes. Additionally, the growing aging population is contributing to the increasing demand for cardiac care technologies.

Looking ahead, the cardiac mapping market is expected to expand with ongoing innovations in medical imaging, data analysis, and digital healthcare solutions. The development of more precise and minimally invasive cardiac diagnostic tools will further enhance treatment efficiency. As healthcare providers focus on improving cardiovascular disease management, the demand for cardiac mapping technologies will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Non-contact Cardiac Mapping Systems
  • Contact Cardiac Mapping Systems

By Disease Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)

By End-user

  • Hospitals
  • Specialty Clinics
  • Cardiac Centers

COMPANIES PROFILED

  • Abbott Laboratories, Acutus Medical Inc, Koninklijke Philips NV, Johnson Johnson Services Inc, Boston Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Medtronic, MicroPort Scientific Corporation, APN Health LLC, AngioDynamics
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC MAPPING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Non-contact Cardiac Mapping Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Contact Cardiac Mapping Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC MAPPING MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Atrial Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Atrial Flutter Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Atrioventricular Nodal Re-Entry Tachycardia (AVNRT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC MAPPING MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC MAPPING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Disease Indication
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Disease Indication
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Disease Indication
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Disease Indication
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Disease Indication
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC MAPPING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Acutus Medical Inc
    • 9.2.3 Koninklijke Philips N.V
    • 9.2.4 Johnson & Johnson Services Inc
    • 9.2.5 Boston Scientific Corporation
    • 9.2.6 Lepu Medical Technology (Beijing) Co. Ltd
    • 9.2.7 Medtronic
    • 9.2.8 MicroPort Scientific Corporation
    • 9.2.9 APN Health LLC
    • 9.2.10 AngioDynamics